Case Report: Presumed digynic triploidy (69,XXX) with a low-risk NIPT result and fetal-placental chromosomal discordance presenting as severe fetal growth restriction in the third trimester

Background Triploidy is a generally lethal chromosomal abnormality with only rare livebirths and no established long-term survival. Although non-invasive prenatal testing (NIPT) is highly effective for common trisomies, its reliability for detecting triploidy is constrained-resulting in delays in prenatal diagnosis. Case presentation A 30-year-old woman presented with progressive severe fetal growth restriction (FGR) and multiple anomalies (bilateral clenched hands, wrist drop, small stomach, right aortic arch with aberrant left subclavian artery) from the second trimester. NIPT at 19 weeks reported low risk for trisomies 21, 18, and 13, with a fetal cell-free DNA (cfDNA) fraction of 3.2%, which was below the laboratory-specific 4% threshold for the BGISEQ-500 assay used in this case. Triploidy was not within the validated reportable scope of this assay. Amniocentesis at 28 weeks with chromosomal microarray analysis (CMA) revealed 69,XXX triploidy. Parental peripheral blood STR analysis confirmed a maternal (digynic) origin. Post-termination, CMA of two independent placental samples showed a 46,XX profile; no triploid cell line was detected in the two sampled sites. These findings indicate fetal-placental chromosomal discordance rather than definitively confirmed confined placental mosaicism. Conclusion This case highlights a multi-layered diagnostic vulnerability: counting-based algorithmic limitations for genome-wide triploidy, low fetal fraction associated with digynic triploidy, and possible biological masking by diploid placental tissue. A low-risk NIPT result for common trisomies does not exclude triploidy, especially when severe FGR and structural anomalies are present. In such high-risk scenarios, clinical management should be guided by fetal imaging rather than cfDNA results, and amniocentesis remains the preferred diagnostic test for definitive fetal karyotyping.

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2026-11-12
DOI
https://doi.org/10.3389/fmed.2026.1993495
Primary Topic
Prenatal Screening and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Case Report: Presumed digynic triploidy (69,XXX) with a low-risk NIPT result and fetal-placental chromosomal discordance presenting as severe fetal growth restriction in the third trimester

Yang Chen, Lei Li
Frontiers in Medicine
Prenatal Screening and Diagnostics
article

Case Report: Presumed digynic triploidy (69,XXX) with a low-risk NIPT result and fetal-placental chromosomal discordance presenting as severe fetal growth restriction in the third trimester

Yang Chen, Lei Li
article en

Abstract

Background Triploidy is a generally lethal chromosomal abnormality with only rare livebirths and no established long-term survival. Although non-invasive prenatal testing (NIPT) is highly effective for common trisomies, its reliability for detecting triploidy is constrained-resulting in delays in prenatal diagnosis. Case presentation A 30-year-old woman presented with progressive severe fetal growth restriction (FGR) and multiple anomalies (bilateral clenched hands, wrist drop, small stomach, right aortic arch with aberrant left subclavian artery) from the second trimester. NIPT at 19 weeks reported low risk for trisomies 21, 18, and 13, with a fetal cell-free DNA (cfDNA) fraction of 3.2%, which was below the laboratory-specific 4% threshold for the BGISEQ-500 assay used in this case. Triploidy was not within the validated reportable scope of this assay. Amniocentesis at 28 weeks with chromosomal microarray analysis (CMA) revealed 69,XXX triploidy. Parental peripheral blood STR analysis confirmed a maternal (digynic) origin. Post-termination, CMA of two independent placental samples showed a 46,XX profile; no triploid cell line was detected in the two sampled sites. These findings indicate fetal-placental chromosomal discordance rather than definitively confirmed confined placental mosaicism. Conclusion This case highlights a multi-layered diagnostic vulnerability: counting-based algorithmic limitations for genome-wide triploidy, low fetal fraction associated with digynic triploidy, and possible biological masking by diploid placental tissue. A low-risk NIPT result for common trisomies does not exclude triploidy, especially when severe FGR and structural anomalies are present. In such high-risk scenarios, clinical management should be guided by fetal imaging rather than cfDNA results, and amniocentesis remains the preferred diagnostic test for definitive fetal karyotyping.

Frontiers in MedicineVol. 13
Qingdao University (CN), Yuhuangding Hospital (CN), Affiliated Hospital of Qingdao University (CN)
Good health and well-being
Prenatal Screening and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon